SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]:
SEC Accession No. 0001104659-13-077368
Filing Date
2013-10-23
Accepted
2013-10-23 19:12:40
Documents
3
Effectiveness Date
2013-10-23

Document Format Files

Seq Description Document Type Size
1 S-1MEF a13-17392_8s1mef.htm S-1MEF 72610
2 EX-5.1 a13-17392_8ex5d1.htm EX-5.1 8012
3 EX-23.1 a13-17392_8ex23d1.htm EX-23.1 4151
  Complete submission text file 0001104659-13-077368.txt   85831
Mailing Address 9363 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9363 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 (514) 337-3333
Mirati Therapeutics, Inc. (Filer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1MEF | Act: 33 | File No.: 333-191872 | Film No.: 131166573
SIC: 2834 Pharmaceutical Preparations